A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: 'Does the use of bilateral mammary artery grafts compared with the use of a single mammary artery graft offer a long-term survival benefit in patients undergoing coronary artery bypass surgery?' Altogether 214 papers were found using the reported search, of which 13 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. All the included studies were follow-up studies; eight studies used prospective data collection, and five studies collected the study data retrospectively. No randomized controlled trials were found. Nine of the 13 included papers used a propensity-score-matched comparison of the survival of bilateral mammary artery graft [or, bilateral internal thoracic artery (BITA) graft] patients vs single mammary artery graft [or, single internal thoracic artery (SITA) graft] patients. These studies consistently showed an enhanced survival of BITA patients compared with propensity-score-matched SITA patients. Three of the 13 included papers used Cox proportional hazards regression analysis to compare survival of BITA vs SITA patients; one larger study showed better crude survival of BITA patients, but did not identify BITA grafts as independent predictor of enhanced survival. The remaining two studies also did not identify BITA grafts as independent predictor of enhanced survival. One study only presented crude survival estimates of BITA vs SITA patients and therefore was of limited informative value. We conclude that the use of BITA grafts seems to offer a long-term survival benefit compared with a SITA graft for patients undergoing coronary artery bypass grafting surgery. Although randomized evidence is lacking, observational evidence supporting this hypothesis is mounting.
Does the use of bilateral mammary artery grafts compared with the use of a single mammary artery graft offer a long-term survival benefit in patients undergoing coronary artery bypass surgery? INTRODUCTION A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] .
THREE-PART QUESTION
In patients undergoing coronary bypass grafting surgery, is the use of bilateral mammary artery bypass grafts superior to the use of a single mammary artery bypass graft in terms of long-term survival?
CLINICAL SCENARIO
You are scheduled to perform an elective coronary bypass grafting procedure and discuss the case with your resident the night before. You plan to revascularize the anterior wall with the left internal mammary artery (LIMA), and discuss the possibilities of revascularization of the lateral and inferior wall with your resident.
He suggests using a second mammary artery graft. You ask him to do a literature search on the latest research on long-term survival of this procedure compared with the use of a saphenous vein graft (SVG).
SEARCH STRATEGY
Medline (PubMed interface) was searched from 1950 until January 2013, using the following criteria: 'Coronary Artery Bypass'[Mesh] AND 'bilateral mammary artery' AND 'Mortality'.
SEARCH OUTCOME
Two hundred and fourteen papers were found using the reported search. Two authors (T.S. and G.T.L.K.) independently assessed all the papers and selected 13 papers that provided the best evidence to answer the question. These are presented in Table 1 . We used the meta-analysis performed in 2001 by Taggart et al. [2] as a starting point and thus excluded all papers that were published Locker et al. [5] performed a retrospective analysis of patients undergoing CABG. At 10-and 15-years of follow-up, patients with multiple arterial grafts (i.e. BITA, BITA and radial artery (RA), or SITA and RA) had a significantly better survival compared with propensity-score-matched SITA patients. Although no separate analysis of BITA grafts (i.e. without patients receiving the combination SITA + RA) compared with propensity-score-matched SITA patients is presented, the crude survival estimates of BITA-only patients and BITA + SVG patients are both significantly better than SITA patients. Also, the Cox proportional hazards model showed that both the use of BITA-only and of BITA + SVG were associated with a significantly lower risk of early mortality compared with SITA.
Kinoshita et al. [6] performed a propensity-score-matched analysis in patients ≥70 years of age and showed that the use of BITA grafts is associated with significantly lower mortality at 5-years of follow-up in these patients.
Kurlansky et al. [7] performed a retrospective analysis of 2197 propensity-score-matched pairs of BITA and SITA patients and showed that BITA grafts offered a long-term survival benefit compared with SITA grafts (at 15-and 25-years of follow-up).
Kieser et al. [8] performed a prospective follow-up study showing that crude mortality was lower in BITA patients compared with SITA patients. However, the adjusted survival benefit was non-significant. Subanalyses of the data showed that age was a potential effect modifier and that BITA grafting might offer a survival benefit in patients <70 years of age.
Mohammadi et al. [9] performed a prospective follow-up study of 1277 BITA patients and 9566 SITA patients. BITA grafting was associated with a significantly lower risk of early mortality, and this survival benefit seemed to be lost in patients older than 60 years of age.
Di Mauro et al. [10] showed in a prospective manner that BITA patients had a significant better 10-year survival compared with propensity-score-matched SITA patients.
Lytle et al. [11] studied 1152 propensity-score-matched pairs of BITA vs SITA patients over a mean period of 16.2 years and found that survival was significantly better among BITA patients compared with SITA patients.
Calafiore et al. [12] found no significant survival benefit of BITA grafting at 10-year follow-up.
Hirotani et al. [13] found no difference in long-term mortality between BITA and SITA patients with diabetes. However, this analysis has the limitation that only crude mortality rates were assessed in a small group of patients (BITA n = 179 vs SITA n = 124).
Endo et al. [14] performed a retrospective analysis among diabetic CABG patients. The data were stratified according to leftventricular ejection fraction. At 7-years of follow-up, crude mortality rates were similar between BITA and SITA patients. Cox proportional hazards analysis showed a non-significant benefit of BITA grafts when assessing all-cause mortality. However, BITA grafts conferred a benefit when assessing the composite endpoint of death, redo coronary surgery or myocardial infarction.
In 2001, Endo et al. [15] found no survival benefit of BITA grafting among more than 1000 patients undergoing CABG.
CLINICAL BOTTOM LINE
Although methodological issues make head-to-head comparison difficult, observational studies suggest that the use of BITA grafts seems to offer a long-term survival benefit compared with SITA for patients undergoing CABG surgery. Although randomized evidence is currently lacking, observational evidence supporting this hypothesis is mounting.
